Madison Avenue Partners, LP
Position in LKFT — Lakefront Biotherapeutics NV
CIK 1801265
NEW YORK, NY
Position in LKFT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$103,365,253
+$29,409,883 QoQ
Shares Held
3,447,807
+39.9% QoQ
Ownership
5.27%
of shares outstanding
% of Portfolio
4.45%
of 13F equity value
Holder Rank
#3
of 78 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LKFT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Madison Avenue Partners, LP holds $266,677,975 across 3 Biotechnology names. LKFT ranks #2 (38.8% of the industry book) .
All Filings in LKFT
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $103,365,253 | 3,447,807 | Shares | Sole | 2026-08-14 | |
| 2026-06-15 | $105,589,623 | 3,606,203 | Shares | Sole | 2026-06-23 | |
| 2026-03-31 | $73,955,370 | 2,465,179 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $72,370,626 | 2,213,169 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $76,061,646 | 2,195,775 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $52,537,537 | 1,877,011 | Shares | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||